Kalbe Farma
Kalbe Farma, officially known as PT Kalbe Farma Tbk, is a leading pharmaceutical company headquartered in Indonesia. Established in 1966, Kalbe Farma has grown to become a prominent player in the healthcare industry, with a strong presence across Southeast Asia. The company focuses on various sectors, including prescription pharmaceuticals, consumer health products, and nutritional supplements. Kalbe Farma is renowned for its innovative approach to healthcare, offering a diverse range of products such as over-the-counter medications, herbal remedies, and advanced nutritional solutions. Its commitment to quality and research has positioned it as a trusted name in the market, achieving significant milestones in product development and distribution. With a robust market position, Kalbe Farma continues to enhance the well-being of communities through its comprehensive healthcare solutions.
DitchCarbon Score
How does Kalbe Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kalbe Farma's score of 21 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kalbe Farma's reported carbon emissions
In 2023, Kalbe Farma reported total carbon emissions of approximately 94,015,170 kg CO2e, with Scope 1 emissions at about 18,484,770 kg CO2e and Scope 2 emissions at approximately 75,530,400 kg CO2e. The company has shown a commitment to reducing its carbon footprint over the years, with total emissions decreasing from about 122,326,800 kg CO2e in 2022 and 101,541,690 kg CO2e in 2021. Kalbe Farma's emissions profile indicates a consistent focus on managing Scope 1 and Scope 2 emissions, which are primarily associated with direct operations and energy consumption. However, there are no specific reduction targets or climate pledges documented, suggesting that while the company is actively monitoring its emissions, it may not have formalised commitments to further reduce its carbon footprint. Overall, Kalbe Farma's emissions data reflects a proactive approach to climate management, with a notable reduction trend in recent years, although further clarity on long-term reduction strategies would enhance their sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 13,879,840 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 65,782,430 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 62,987,250 | 00,000,000 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kalbe Farma is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
